Literature DB >> 24334721

Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy.

Jeffrey B Geske1, Tomas Konecny1, Steve R Ommen1, Rick A Nishimura1, Paul Sorajja1, Hartzell V Schaff2, Michael J Ackerman1, Bernard J Gersh3.   

Abstract

AIMS: Characterization of pulmonary hypertension (PH) and the effects of myectomy in hypertrophic cardiomyopathy (HCM) remain poorly defined. The aim of the study was to investigate the effect of myectomy on PH in HCM. METHODS AND
RESULTS: This is a retrospective analysis of 306 consecutive symptomatic HCM patients (70% NYHA class III-IV) with evaluation of echocardiographic right ventricular systolic pressure (RVSP) both preceding (median 3 days) and following (median 4 days) myectomy. Compared with patients without PH (RVSP <35 mmHg, n = 145, 47%), patients with moderate or severe PH (RVSP ≥50 mmHg, n = 51, 17%) were older, predominantly female, had a greater prevalence of atrial fibrillation, higher natriuretic peptide levels, higher left ventricular outflow tract gradient, higher E velocity, and larger left atria. Reduction of RVSP post-myectomy was evident in patients with moderate or severe PH [59 (IQR 54-71) to 50 (IQR 39-62) mmHg, P < 0.0001] and in all patients with PH [RVSP ≥ 35 mmHg, n = 161, 43 (IQR 39-54) to 41 (IQR 35-52) mmHg, P < 0.0001]. In a subgroup of patients with long-term data, PH continued to decline during follow-up. Clinical variables associated with improvement in PH in these patients were higher left atrial volume index (R = 0.43, P = 0.0069) and moderate or severe mitral regurgitation (R = 0.33, P = 0.038).
CONCLUSION: Surgical myectomy is associated with improvement in PH, most pronounced in moderate or severe PH. These data provide insight into pulmonary haemodynamics following obstruction relief and can help to guide therapeutic expectations. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2013. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Pulmonary hypertension; Septal reduction therapy

Mesh:

Year:  2013        PMID: 24334721     DOI: 10.1093/eurheartj/eht537

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.

Authors:  Michele Covella; Ethan J Rowin; Nicholas S Hill; Ioana R Preston; Alberto Milan; Alexander R Opotowsky; Barry J Maron; Martin S Maron; Bradley A Maron
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

2.  Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging.

Authors:  You-Zhou Chen; Xing-Shan Zhao; Jian-Song Yuan; Yan Zhang; Wei Liu; Shu-Bin Qiao
Journal:  Biol Sex Differ       Date:  2022-07-07       Impact factor: 8.811

3.  Impact of septal myectomy on diastolic function in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Qiulan Yang; Hao Cui; Changsheng Zhu; Haibo Hu; Jianhua Lv; Yao Liu; Yang Zhang; Hartzell V Schaff; Shuiyun Wang
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

4.  Women with hypertrophic cardiomyopathy have worse survival.

Authors:  Jeffrey B Geske; Kevin C Ong; Konstantinos C Siontis; Virginia B Hebl; Michael J Ackerman; David O Hodge; Virginia M Miller; Rick A Nishimura; Jae K Oh; Hartzell V Schaff; Bernard J Gersh; Steve R Ommen
Journal:  Eur Heart J       Date:  2017-12-07       Impact factor: 29.983

5.  Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Zhengyang Lu; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.